文献速递复苏、休克与脓毒症心脑血管急症

低剂量肾上腺素给药与院外心脏骤停结局

Lower-dose epinephrine administration and out-of-hospital cardiac arrest outcomes.
PubMed 文献 · Resuscitation · 2018-01-03
一句话结论院外心脏骤停中降低肾上腺素剂量与生存出院或良好神经结局无显著关联,国际指南推荐的1 mg每3-5分钟方案未改变。

本研究纳入2008年1月1日至2016年6月30日由高级生命支持提供者治疗的非创伤性院外心脏骤停患者2255例,比较降低肾上腺素剂量方案(可除颤心律:4分钟0.5 mg,8分钟0.5 mg,之后每8分钟0.5 mg;不可除颤心律:每2分钟0.5 mg)与较高剂量方案(可除颤心律:4分钟1 mg,之后每8分钟1 mg;不可除颤心律:每2分钟1 mg)。结果显示,低剂量与高剂量相比,生存出院和良好神经结局均无显著差异(可除颤心律生存aOR 0.91,95%CI 0.62-1.32;不可除颤心律aOR 1.26,95%CI 0.79-2.01)。结论提示降低肾上腺素剂量未改变院外心脏骤停后的生存或神经结局。

要点

  • 可除颤心律患者中,高剂量组生存出院35.0% vs 低剂量组34.2%,调整后OR 0.91(95%CI 0.62-1.32)。
  • 不可除颤心律患者中,高剂量组生存出院4.2% vs 低剂量组5.1%,调整后OR 1.26(95%CI 0.79-2.01)。
  • 良好神经结局(CPC 1或2)在可除颤心律中aOR 0.84(95%CI 0.57-1.24),不可除颤心律中aOR 1.17(95%CI 0.68-2.02)。
  • 每例患者总肾上腺素剂量在可除颤组从3.4±2.3 mg降至2.6±1.9 mg(p<0.001),不可除颤组从3.5±1.9 mg降至2.8±1.7 mg(p<0.001)。
  • 国际指南推荐心脏骤停期间每3-5分钟静脉给予1 mg肾上腺素。

适用人群与场景

  • 2008年1月1日至2016年6月30日由高级生命支持提供者治疗的非创伤性院外心脏骤停患者。
  • 按初始心律分为可除颤心律和不可除颤心律两组分别分析。

处置流程与药物剂量

  • 较高剂量方案:可除颤心律患者4分钟静脉给予1 mg肾上腺素,之后每8分钟追加1 mg;不可除颤心律患者每2分钟静脉给予1 mg。
  • 较低剂量方案:可除颤心律患者4分钟和8分钟各静脉给予0.5 mg,之后每8分钟追加0.5 mg;不可除颤心律患者每2分钟静脉给予0.5 mg。
  • 国际指南推荐心脏骤停期间每3-5分钟静脉给予1 mg肾上腺素。

研究设计与关键结果

  • 研究类型为前后对照的观察性研究,纳入2255例院外心脏骤停患者,其中24.6%为初始可除颤心律。
  • 主要终点生存出院:可除颤心律高剂量组35.0% vs 低剂量组34.2%,调整后OR 0.91(95%CI 0.62-1.32,p=0.61);不可除颤心律高剂量组4.2% vs 低剂量组5.1%,调整后OR 1.26(95%CI 0.79-2.01,p=0.33)。
  • 次要终点良好神经结局(CPC 1或2):可除颤心律调整后OR 0.84(95%CI 0.57-1.24,p=0.377);不可除颤心律调整后OR 1.17(95%CI 0.68-2.02,p=0.577)。
  • 每例患者总肾上腺素剂量:可除颤心律从3.4±2.3 mg降至2.6±1.9 mg(p<0.001),不可除颤心律从3.5±1.9 mg降至2.8±1.7 mg(p<0.001)。
  • 多因素logistic回归调整了年龄、性别、目击者、旁观者CPR和响应间隔。

证据类型、等级与局限

  • 证据类型:观察性前后对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为降低院外心脏骤停期间肾上腺素剂量与生存出院或良好神经结局改变无关。
  • 国际指南推荐心脏骤停期间每3-5分钟静脉给予1 mg肾上腺素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: International guidelines recommend administration of 1 mg of intravenous epinephrine every 3-5 min during cardiac arrest. The optimal dose of epinephrine is not known. We evaluated the association of reduced frequency and dose of epinephrine with survival after out-of-hospital cardiac arrest (OHCA).

METHODS: Included were patients with non-traumatic OHCA treated by advanced life support (ALS) providers from January 1, 2008 to June 30, 2016. During the before period, providers were instructed to give epinephrine 1 mg intravenously at 4 min followed by additional 1 mg doses every eight minutes to patients with OHCA with a shockable rhythm and 1 mg doses every two minutes to patients with a non-shockable rhythm (higher dose). On October 1, 2012, providers were instructed to reduce the dose of epinephrine treatment during out-of-hospital cardiac arrest (OHCA): 0.5 mg at 4 and 8 min followed by additional doses of 0.5 mg every 8 min for shockable rhythms and 0.5 mg every 2 min for non-shockable rhythms (lower dose). Patients with shockable initial rhythms were analyzed separately from those with non-shockable initial rhythms. The primary outcome was survival to hospital discharge with a secondary outcome of favorable neurological status (Cerebral Performance Category [CPC] 1 or 2) at hospital discharge. Multiple logistic regression modeling was used to adjust for age, sex, presence of a witness, bystander CPR, and response interval.

RESULTS: 2255 patients with OHCA were eligible for analysis. Of these, 24.6% had an initially shockable rhythm. Total epinephrine dose per patient decreased from a mean ± standard deviation of 3.4 ± 2.3 mg-2.6 ± 1.9 mg (p < 0.001) in the shockable group and 3.5 ± 1.9 mg-2.8 ± 1.7 mg (p < 0.001) in the non-shockable group. Among those with a shockable rhythm, survival to hospital discharge was 35.0% in the higher dose group vs. 34.2% in the lower dose group. Among those with a non-shockable rhythm, survival was 4.2% in the higher dose group vs. 5.1% in the lower dose group. Lower dose vs. higher dose was not significantly associated with survival: adjusted odds ratio, aOR 0.91 (95% CI 0.62-1.32, p = 0.61) if shockable and aOR 1.26 (95% CI 0.79-2.01, p = 0.33) if non-shockable. Lower dose vs. higher dose was not significantly associated with favorable neurological status at discharge: aOR 0.84 (95% CI 0.57-1.24, p = 0.377) if shockable and aOR 1.17 (95% CI 0.68-2.02, p = 0.577) if non-shockable.

CONCLUSION: Reducing the dose of epinephrine administered during out-of-hospital cardiac arrest was not associated with a change in survival to hospital discharge or favorable neurological outcomes after OHCA.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Fisk CA, Olsufka M, Yin L, et al. Lower-dose epinephrine administration and out-of-hospital cardiac arrest outcomes. Resuscitation. 2018. PMID: 29305926. doi:10.1016/j.resuscitation.2018.01.004

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。